Drug · DIN 02457997
IZBA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 3, 2018; first marketed February 6, 2017.
- Drug Identification Number (DIN)
- 02457997
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Travoprost S01EE04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRAVOPROST | 0.003 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 13, 2017: NOC 19057New Drug Submission (NDS) · Transfer of drug identification number
- September 23, 2016: NOC 18510New Drug Submission (NDS)